Profound Medical Ownership
| PROF Stock | USD 6.23 0.21 3.26% |
Shares in Circulation | First Issued 2014-03-31 | Previous Quarter 30.1 M | Current Value 30.1 M | Avarage Shares Outstanding 14.1 M | Quarterly Volatility 9.1 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. Profound Stock Ownership Analysis
About 36.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.32. Profound Medical Corp last dividend was issued on the 16th of October 2019. The entity had 1:10 split on the 16th of October 2019. Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada. Profound Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 146 people. To find out more about Profound Medical Corp contact Arun MBA at 647 476 1350 or learn more at https://www.profoundmedical.com.Besides selling stocks to institutional investors, Profound Medical also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Profound Medical's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Profound Medical's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Profound Medical Quarterly Liabilities And Stockholders Equity |
|
About 11.0% of Profound Medical Corp are currently held by insiders. Unlike Profound Medical's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Profound Medical's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Profound Medical's insider trades
Profound Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Profound Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Profound Medical Corp backward and forwards among themselves. Profound Medical's institutional investor refers to the entity that pools money to purchase Profound Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Carolina Wealth Advisors, Llc | 2025-06-30 | 2 K |
Profound Medical Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Profound Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Profound Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Profound Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Menawat Arun Swarup over six months ago Acquisition by Menawat Arun Swarup of 12027 shares of Profound Medical at 4.73 subject to Rule 16b-3 | ||
Menawat Arun Swarup over six months ago Acquisition by Menawat Arun Swarup of 10003 shares of Profound Medical at 4.325 subject to Rule 16b-3 | ||
Hofer Michael over a year ago Acquisition by Hofer Michael of 500000 shares of Profound Medical at 0.0014 subject to Rule 16b-3 |
Profound Medical Outstanding Bonds
Profound Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Profound Medical Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Profound bonds can be classified according to their maturity, which is the date when Profound Medical Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Profound Medical Corporate Filings
8K | 12th of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 22nd of December 2025 Other Reports | ViewVerify | |
| 4th of December 2025 Other Reports | ViewVerify | |
10Q | 13th of November 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Profound have expansion opportunities? Factors like these will boost the valuation of Profound Medical. Anticipated expansion of Profound directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Profound Medical demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (1.32) | Revenue Per Share | Quarterly Revenue Growth 0.868 | Return On Assets | Return On Equity |
Investors evaluate Profound Medical Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Profound Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Profound Medical's market price to deviate significantly from intrinsic value.
It's important to distinguish between Profound Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Profound Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Profound Medical's market price signifies the transaction level at which participants voluntarily complete trades.